Copyright Reports & Markets. All rights reserved.

Global HIV Supplemental Assays and Control Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global HIV Supplemental Assays and Control Kit Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 HIV-1 Test
    • 1.3.3 HIV-2 Test
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global HIV Supplemental Assays and Control Kit Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global HIV Supplemental Assays and Control Kit Market Size & Forecast
    • 1.5.1 Global HIV Supplemental Assays and Control Kit Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global HIV Supplemental Assays and Control Kit Sales Quantity (2020-2031)
    • 1.5.3 Global HIV Supplemental Assays and Control Kit Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Bio-Rad Laboratories
    • 2.1.1 Bio-Rad Laboratories Details
    • 2.1.2 Bio-Rad Laboratories Major Business
    • 2.1.3 Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Product and Services
    • 2.1.4 Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Bio-Rad Laboratories Recent Developments/Updates
  • 2.2 INSTI
    • 2.2.1 INSTI Details
    • 2.2.2 INSTI Major Business
    • 2.2.3 INSTI HIV Supplemental Assays and Control Kit Product and Services
    • 2.2.4 INSTI HIV Supplemental Assays and Control Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 INSTI Recent Developments/Updates
  • 2.3 Hologic
    • 2.3.1 Hologic Details
    • 2.3.2 Hologic Major Business
    • 2.3.3 Hologic HIV Supplemental Assays and Control Kit Product and Services
    • 2.3.4 Hologic HIV Supplemental Assays and Control Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Hologic Recent Developments/Updates
  • 2.4 Sedia Biosciences Corporation
    • 2.4.1 Sedia Biosciences Corporation Details
    • 2.4.2 Sedia Biosciences Corporation Major Business
    • 2.4.3 Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Product and Services
    • 2.4.4 Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sedia Biosciences Corporation Recent Developments/Updates

3 Competitive Environment: HIV Supplemental Assays and Control Kit by Manufacturer

  • 3.1 Global HIV Supplemental Assays and Control Kit Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global HIV Supplemental Assays and Control Kit Revenue by Manufacturer (2020-2025)
  • 3.3 Global HIV Supplemental Assays and Control Kit Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of HIV Supplemental Assays and Control Kit by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 HIV Supplemental Assays and Control Kit Manufacturer Market Share in 2024
    • 3.4.3 Top 6 HIV Supplemental Assays and Control Kit Manufacturer Market Share in 2024
  • 3.5 HIV Supplemental Assays and Control Kit Market: Overall Company Footprint Analysis
    • 3.5.1 HIV Supplemental Assays and Control Kit Market: Region Footprint
    • 3.5.2 HIV Supplemental Assays and Control Kit Market: Company Product Type Footprint
    • 3.5.3 HIV Supplemental Assays and Control Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global HIV Supplemental Assays and Control Kit Market Size by Region
    • 4.1.1 Global HIV Supplemental Assays and Control Kit Sales Quantity by Region (2020-2031)
    • 4.1.2 Global HIV Supplemental Assays and Control Kit Consumption Value by Region (2020-2031)
    • 4.1.3 Global HIV Supplemental Assays and Control Kit Average Price by Region (2020-2031)
  • 4.2 North America HIV Supplemental Assays and Control Kit Consumption Value (2020-2031)
  • 4.3 Europe HIV Supplemental Assays and Control Kit Consumption Value (2020-2031)
  • 4.4 Asia-Pacific HIV Supplemental Assays and Control Kit Consumption Value (2020-2031)
  • 4.5 South America HIV Supplemental Assays and Control Kit Consumption Value (2020-2031)
  • 4.6 Middle East & Africa HIV Supplemental Assays and Control Kit Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global HIV Supplemental Assays and Control Kit Sales Quantity by Type (2020-2031)
  • 5.2 Global HIV Supplemental Assays and Control Kit Consumption Value by Type (2020-2031)
  • 5.3 Global HIV Supplemental Assays and Control Kit Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global HIV Supplemental Assays and Control Kit Sales Quantity by Application (2020-2031)
  • 6.2 Global HIV Supplemental Assays and Control Kit Consumption Value by Application (2020-2031)
  • 6.3 Global HIV Supplemental Assays and Control Kit Average Price by Application (2020-2031)

7 North America

  • 7.1 North America HIV Supplemental Assays and Control Kit Sales Quantity by Type (2020-2031)
  • 7.2 North America HIV Supplemental Assays and Control Kit Sales Quantity by Application (2020-2031)
  • 7.3 North America HIV Supplemental Assays and Control Kit Market Size by Country
    • 7.3.1 North America HIV Supplemental Assays and Control Kit Sales Quantity by Country (2020-2031)
    • 7.3.2 North America HIV Supplemental Assays and Control Kit Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe HIV Supplemental Assays and Control Kit Sales Quantity by Type (2020-2031)
  • 8.2 Europe HIV Supplemental Assays and Control Kit Sales Quantity by Application (2020-2031)
  • 8.3 Europe HIV Supplemental Assays and Control Kit Market Size by Country
    • 8.3.1 Europe HIV Supplemental Assays and Control Kit Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe HIV Supplemental Assays and Control Kit Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific HIV Supplemental Assays and Control Kit Market Size by Region
    • 9.3.1 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific HIV Supplemental Assays and Control Kit Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America HIV Supplemental Assays and Control Kit Sales Quantity by Type (2020-2031)
  • 10.2 South America HIV Supplemental Assays and Control Kit Sales Quantity by Application (2020-2031)
  • 10.3 South America HIV Supplemental Assays and Control Kit Market Size by Country
    • 10.3.1 South America HIV Supplemental Assays and Control Kit Sales Quantity by Country (2020-2031)
    • 10.3.2 South America HIV Supplemental Assays and Control Kit Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa HIV Supplemental Assays and Control Kit Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa HIV Supplemental Assays and Control Kit Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa HIV Supplemental Assays and Control Kit Market Size by Country
    • 11.3.1 Middle East & Africa HIV Supplemental Assays and Control Kit Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa HIV Supplemental Assays and Control Kit Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 HIV Supplemental Assays and Control Kit Market Drivers
  • 12.2 HIV Supplemental Assays and Control Kit Market Restraints
  • 12.3 HIV Supplemental Assays and Control Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of HIV Supplemental Assays and Control Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of HIV Supplemental Assays and Control Kit
  • 13.3 HIV Supplemental Assays and Control Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 HIV Supplemental Assays and Control Kit Typical Distributors
  • 14.3 HIV Supplemental Assays and Control Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global HIV Supplemental Assays and Control Kit market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    HIV Supplemental Assays and Control Kits are crucial components in the laboratory diagnosis and confirmation of HIV (Human Immunodeficiency Virus) infection. These tools are used to validate initial screening results, ensuring accurate and reliable detection of HIV.
    This report is a detailed and comprehensive analysis for global HIV Supplemental Assays and Control Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global HIV Supplemental Assays and Control Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global HIV Supplemental Assays and Control Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global HIV Supplemental Assays and Control Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global HIV Supplemental Assays and Control Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for HIV Supplemental Assays and Control Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global HIV Supplemental Assays and Control Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, INSTI, Hologic, Sedia Biosciences Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    HIV Supplemental Assays and Control Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    HIV-1 Test
    HIV-2 Test
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Bio-Rad Laboratories
    INSTI
    Hologic
    Sedia Biosciences Corporation
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe HIV Supplemental Assays and Control Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of HIV Supplemental Assays and Control Kit, with price, sales quantity, revenue, and global market share of HIV Supplemental Assays and Control Kit from 2020 to 2025.
    Chapter 3, the HIV Supplemental Assays and Control Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the HIV Supplemental Assays and Control Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HIV Supplemental Assays and Control Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of HIV Supplemental Assays and Control Kit.
    Chapter 14 and 15, to describe HIV Supplemental Assays and Control Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now